Silo Pharma’s PTSD Program Gains Momentum Amid Federal Push for Psychedelic Therapies
Market Chameleon (Mon, 20-Apr 11:45 AM)
European Patent Allowance Expands Silo Pharma’s IP Portfolio for PTSD Therapy—What Does This Mean for the Company’s Pipeline?
Market Chameleon (Tue, 7-Apr 9:53 AM)
